Translation efficiency of the human T-cell leukemia virus (HTLV-2) gag gene modulates the frequency of ribosomal frameshifting.
The regulation of ribosomal frameshifting during translation of the polycistronic mRNA of human T-cell leukemia virus (HTLV) was studied in a cell-free system. Translation inhibitors such as cycloheximide and puromycin antibiotics were much more effective in blocking the synthesis of the frameshift polypeptide Gag-Pro than the synthesis of the Gag product. The preferential inhibition of the frameshift polypeptide Gag-Pro by the two antibiotics was not a reflection of the different sizes of the two gene products, but rather a consequence of the effect of the inhibitors on ribosomal translation efficiencies. To further analyze the effect of translation efficiencies on ribosomal frameshifting, we compared the translation of 5'-capped RNA to noncapped RNA. The translation of 5'-capped RNA was higher, as expected. Consequently, ribosomal frameshifting producing the Gag-Pro polypeptide was enhanced when compared to the translation of noncapped RNA. Taken together these results indicate that efficiencies of translation, in conjunction with the cis regulatory genetic elements at the frameshift sites, determine the ratio of the polypeptides Gag, Gag-Pro, and Gag-Pro-Pol produced in the HTLV-infected cell. Thus, physiological changes which affect the cellular translation machinery may alter the optimal ratio of these three polyprotein products needed for virus maturation.
Honigman
A
A
Department of Molecular Genetics, The Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Falk
H
H
Mador
N
N
Rosental
T
T
Panet
A
A
D002474:Cell-Free System; D018965:Frameshifting, Ribosomal; D015683:Gene Products, gag / Q000235:genetics*; D015367:Human T-lymphotropic virus 2 / Q000502:physiology*; D006801:Humans; D012270:Ribosomes / Q000235:genetics*; D014779:Virus Replication / Q000235:genetics
D015683:Gene Products, gag